The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer.
Jana de BonifaceJohan AhlgrenYvette AnderssonLeif BergkvistJan FrisellDan LundstedtRoger Olofsson BaggeLisa RydénMalin Sundnull nullPublished in: Breast cancer research and treatment (2020)
NCT02240472, retrospective registration date September 14, 2015 after trial initiation on January 31, 2015.